 |
 |
|
 |
 |
 |
 |
 |
 |
|
Encyclopedia -> Disease -> D -> Disseminated tuberculosis (infectious) Alternate Names: Miliary tuberculosis; Tuberculosis - disseminated Causes and Risks: The infection can develop after inhaling droplets sprayed into the air as from a cough or sneeze by someone infected with Mycobacterium tuberculosis. The disease is characterized by the development of granulomas (granular tumors) in the infected tissues. The usual site of the disease is the lungs, but other organs may be involved. Primary infection is usually asymptomatic. In the United States, 95% of individuals will have healing of their primary tuberculous lesions with no further evidence of disease. Disseminated disease develops in the minority whose immune systems do not successfully heal the primary infection. The disease may occur within weeks after the primary infection, or may lie dormant for years before causing illness. Infants and the elderly are at higher risk for rapid progression to disease. In disseminated disease, organs and tissues affected can include the lining of the heart (pericardium), lining of the abdominal cavity (peritoneum), larynx, bronchus, cervical lymph nodes, bones and joints, organs of the male or female urinary and reproductive (genitourinary) system, eye, stomach, lining of the brain and spinal cord (meninges), and skin. The risk of contracting TB increases with the frequency of contact with people who have the disease, in crowded or unsanitary living conditions, and with poor nutrition. Hispanics, Native Americans, and blacks are at higher risk for developing the disease. An increased incidence of TB has been seen recently in the United States. Factors that may be causing this increase is tuberculous infection in people with AIDS and HIV infection, and increasing number of homeless people. Another factor is the development of drug-resistant strains of TB. Incomplete treatment of TB infections (such as not taking medications for the prescribed length of time) can contribute to the proliferation of drug-resistant strains of bacteria. The incidence is 4 out of 10,000 people and increasing. Disseminated TB is more common in AIDS patients. About half of AIDS patients with a CD4 count less than 200 who develop TB will have disseminated disease. Prevention: Vaccination BCG for tuberculin-negative persons exposed to persons with untreated TB is given in some situations, but its effectiveness is under dispute. Symptoms: In adults and children:
Additional symptoms that may be associated with this disease:
Note: The symptoms will depend upon the affected body organ. Signs and Tests: Enlarged lymph nodes, enlarged liver, and enlarged spleen are revealed with physical exam.
This disease may also alter the results of the following tests:
Treatment: The goal of treatment is to cure the infection with antitubercular drugs. These drugs include ethionamide, para-aminosalicylic acid (PAS), pyrazinamide, isoniazid (INH), rifampin, ethambutol, and streptomycin. Daily oral doses are continued for 1 year. For atypical tuberculosis infections, or drug-resistant strains, other drugs may be indicated to treat the infection. A minimum of three drugs are started for treatment. Hospitalization is indicated to prevent the spread of the disease to others until the infectious period is over, usually 2 to 4 weeks after the start of therapy. Normal activity can be continued after the infectious period. Prognosis: Most disseminated forms of tuberculosis respond well to treatment. Complications: All medications used to treat TB have some toxicity. Rifampin and isoniazid may both cause a non-infectious hepatitis. Rifampin may also cause an orange or brown coloration of tears and urine. Other complications include:
|
||||||||||||||||||||
